Enanta Pharmaceuticals (ENTA) Cash from Operations (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.83% |
| Dec 31, 2025 | -80.29% |
| Sep 30, 2025 | -137.07% |
| Jun 30, 2025 | 229.79% |
| Mar 31, 2025 | 19.72% |
| Dec 31, 2024 | -61.55% |
| Sep 30, 2024 | 29.61% |
| Jun 30, 2024 | 48.34% |
| Mar 31, 2024 | -14.46% |
| Dec 31, 2023 | -15.67% |
| Sep 30, 2023 | 32.76% |
| Jun 30, 2023 | -133.10% |
| Mar 31, 2023 | 61.33% |
| Dec 31, 2022 | -129.44% |
| Sep 30, 2022 | 47.52% |
| Jun 30, 2022 | -12.24% |
| Mar 31, 2022 | -98.74% |
| Dec 31, 2021 | 36.87% |
| Sep 30, 2021 | 28.76% |
| Jun 30, 2021 | -544.38% |
| Mar 31, 2021 | 69.25% |
| Dec 31, 2020 | 3.69% |
| Sep 30, 2020 | -244.50% |
| Jun 30, 2020 | -130.58% |
| Mar 31, 2020 | 18.69% |
| Dec 31, 2019 | 44.68% |
| Sep 30, 2019 | 237.35% |
| Jun 30, 2019 | -91.58% |
| Mar 31, 2019 | -0.56% |
| Dec 31, 2018 | 6.75% |
| Sep 30, 2018 | 600.12% |
| Jun 30, 2018 | 153.42% |
| Mar 31, 2018 | -271.88% |
| Dec 31, 2017 | -92.31% |
| Sep 30, 2017 | 1,294.87% |
| Jun 30, 2017 | -59.76% |
| Mar 31, 2017 | -195.45% |
| Dec 31, 2016 | 247.93% |
| Sep 30, 2016 | -0.66% |
| Jun 30, 2016 | -121.01% |
| Mar 31, 2016 | -66.48% |
| Dec 31, 2015 | 1,362.86% |
| Sep 30, 2015 | 83.28% |
| Jun 30, 2015 | -114.37% |
| Mar 31, 2015 | 1,862.23% |
| Dec 31, 2014 | -13.75% |
| Sep 30, 2014 | -114.05% |
| Jun 30, 2014 | 950.17% |
| Mar 31, 2014 | 29.65% |
| Dec 31, 2013 | -134.56% |
| Sep 30, 2013 | 57.73% |
| Jun 30, 2013 | -159.03% |
| Mar 31, 2013 | 10.92% |
| Dec 31, 2012 | 631.43% |
| Sep 30, 2012 | 55.54% |